irasia.com - Pharmaxis Ltd

You will need the Adobe Acrobat Reader 7.0 to view the PDF.
If you do not have any of the above, please download "Acrobat Reader".

2004-December-23	US FDA Grants Approval for Aridol ^TM Phase III Trial (in PDF)
2004-December-14	Successful Share Purchase Plan Lifts Total Proceeds from Recent Capital Raisings to $19.7 Million (in PDF)
2004-November-26	Pharmaxis Secures US Patent for Multiple Sclerosis Treatment (in PDF)
2004-November-22	Pharmaxis Files Aridol IND in the USA (in PDF)
2004-November-12	Pharmaxis Establishes Level One American Depositary Receipt (ADR) Program (in PDF)
2004-October-26	Pharmaxis Aridol Asthma Trial Successful (in PDF)
2004-October-1	Aridol^TM Update (in PDF)
2004-September-27	Pharmaxis Announces Positive Results from Phase II Trial of Bronchitol^TM (in PDF)
2004-August-12	Aridol^TM Selected for Major Independent UK Clinical Study by General Practitioners (in PDF)
2004-July-30	Pharmaxis Successfully Completes Enrolment for its 600-Patient Phase III Trial of Aridol^TM in Asthma (in PDF)
2004-July-16	Pharmaxis Successfully Completes Patient Enrolment for its Phase II Trial of Bronchitol^TM in the Lung Disease Bronchiectasis (in PDF)
2008	2008 Press Releases
2007	2007 Press Releases
2006	2006 Press Releases
2005	2005 Press Releases